Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
This is a nationwide cohort study on real-world patients (n≈30,000) surviving a first myocardial infarction (MI) 2006-2013 and alive to attend a routine 1-year follow-up. Associations between Socioeconomic Status (SES) and secondary preventive actions (SPAs) throughout the first year is studied and assessed as possible mechanisms underlying the increased risk of a first recurrent hard cardiocvascular (CV) outcome, recurrent atherosclerotic cardiovascular disease (rASCVD), in patients with low Socioeconomic Status during long-term follow-up (2006-2018).
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| categories of Socioeconomic Status (SES) | by proxy gender- and calendar year-specific quintiles of disposable income per household consumption unit. In logistic regression models of associations with secondary prevention activities and established treatment goals: highest vs. lowest income quintile. In multivariable Cox regression analyses with stepwise built models: quintiles of disposable income and models including covariates level of education and marital status. |
Not provided
| Measure | Description | Time Frame |
|---|---|---|
| first recurrent atherosclerotic cardiovascular disease event (rASCVD) | composite outcome including non-fatal MI (I210-I214, I219, I220, I221, I228 or I229) or coronary heart disease death (CHD) (I210-I214, I219, I220, I221, I228, I229, I461 or I469) or fatal or non-fatal ischemic stroke (I630-I635, I638 or I639) according to the International Classification of Diseases 10th edition (ICD-10) | from date of 1-year visit post-MI (baseline) until date of outcome, censoring or study end (2018) |
Not provided
| Measure | Description | Time Frame |
|---|---|---|
| Goal: physical training program | participated in organized physical training program after the initial care | at 1-year revisit |
| Goal: LDL-C goal | attained LDL-C level below treatment target |
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
large nation-wide population of consecutive patients with assumed stable coronary heart disease after a myocardial infarction (first manifestation of atherosclerotic cardiovascular disease) in a tax-funded health care system.
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Per O Svensson, MD PhD | Department of Clinical Science and Education, Söderjukhuset | Principal Investigator |
Not provided
Not provided
| ID | Term |
|---|---|
| D009203 | Myocardial Infarction |
| D002318 | Cardiovascular Diseases |
| D020521 | Stroke |
| ID | Term |
|---|---|
| D017202 | Myocardial Ischemia |
| D006331 | Heart Diseases |
| D014652 | Vascular Diseases |
| D007238 | Infarction |
Not provided
Not provided
Not provided
Not provided
Not provided
| at 1-year revisit |
| Goal: Blood pressure goal | attained blood pressure levels below treatment target | at 1-year revisit |
| Goal: smoking cessation | Patients being current smokers at their initial care who successfully quit smoking. | at 1-year revisit |
| Goal: physical activity | reported >30 minutes of physical activity ≥5 times a week | at 1-year revisit |
| Goal: statin treatment | on statin treatment 1 year after the index MI | at 1-year revisit |
| Goal: Renin-angiotensin-aldosteron system (RAAS)-inhibition | Patients with congestive heart failure, diabetes or hypertension at the index Mi on treatment with angiotensin converting enzyme inhibitor or angiotensin receptor blocker. | at 1-year revisit |
| Goal: HbA1c goal | Patients with diabetes with attained HbA1c treatment target | at 1-year revisit |
| SPA: cardiac rehabilitation program | participation in structured program after the index MI | during 1st year after initial care |
| SPA: diet course | participation in course after the index MI | during 1st year after initial care |
| SPA: statin intensity increase | statin intensity increase decided at routine revisits (Dosages categorized into high (Rosuvastatin 20-40 mg or Atorvastatin 40-80 mg), moderate (Rosuvastatin 5-10 mg, Atorvastatin 10-20 mg, or Simvastatin 20-40 mg) and low (Simvastatin 10 mg)) | 2 months or 1 year after initial care |
| SPA: high intensity statins | on high intensity statin treatment (Rosuvastatin 20-40 mg or Atorvastatin 40-80 mg) | at 1-year revisit |
| SPA: LDL-C reduction | LDL-C reduction between routine revisits | 2 months and 1 year after initial care |
| SPA: lipid monitoring | Blood lipid panel measured | 2 months or 1 year after initial care |
| SPA: type of follow-up | decided follow-up by office revisit or by phone | 2 month revisit |
| SPA: reperfusion | type of reperfusion treatment chosen in STEMI and NSTEMI | initial care |
| SPA: revascularized | achieved complete revascularization in STEMI and NSTEMI | initial care |
| SPA: staged procedure | Decision on continued invasive procedures at a later stage | initial care |
| SPA: smoking cessation counseling | received through cessation program or counseling | 2 months or 1 year after initial care |
| SPA: HbA1c monitoring | Patients with diabetes at initial care having their HbA1c measured at least twice | during initial care, at 2 months and 1 year after initial care |
| SPA: Anti-stress program | Patients reporting anxiety or sadness participating in anti-stress program | 1 year after initial care |
| SPA: counter-metabolic syndrome actions | Patients with the metabolic syndrome participating in physical training and diet course or in cardiac rehabilitation program | 2 months or 1 year after initial care |
| D007511 |
| Ischemia |
| D010335 | Pathologic Processes |
| D013568 | Pathological Conditions, Signs and Symptoms |
| D009336 | Necrosis |
| D002561 | Cerebrovascular Disorders |
| D001927 | Brain Diseases |
| D002493 | Central Nervous System Diseases |
| D009422 | Nervous System Diseases |